News Column

Harbin Pharmaceutical 2013 Net Expected to Down 60%-70%

January 23, 2014

HARBIN , January 23 , SinoCast -- Harbin Pharmaceutical Group Co., Ltd. (SHSE: 600664) predicted net profit attributable to shareholders in 2013 to decline 60% to 70% from a year earlier, when the figure reached CNY 499.65 million .


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Sinocast Health Care & Medicine Beat (China)


Story Tools